Description
HIV p17 Gag (77-85) is an immunodominant Gag epitope peptide used to prime activated CD8+ cytotoxic T cells (CTLs) in the design of vaccines against HIV-1.
Product Unit Size | Cost | Quantity | Stock |
---|
HIV p17 Gag (77-85) is an immunodominant Gag epitope peptide used to prime activated CD8+ cytotoxic T cells (CTLs) in the design of vaccines against HIV-1.
Purity | ≥98% |
---|---|
Formula | C44H72N10O15 |
Formula Wt. | 981.1 |
Synonym | HIV-1 p17 (77-85), SL9. |
Solubility | Soluble in water, DMSO. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Kan-Mitchell J, Bajcz M, Schaubert KL, et al. Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response. J Immunol. 2006 Jun 1;176(11):6690-701. PMID: 16709828.
Kan-Mitchell J, Bisikirska B, Wong-Staal F, et al. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope. J Immunol. 2004 May 1;172(9):5249-61. PMID: 15100263.
Calcium channel blocker.
Isoflavone daidzein derivative found in Puerari...
Synthetic ghrelin analog; ghrelin agonist.
α-Linked disaccharide composed of α-glucose u...
Endogenous catecholamine precursor, also found ...
Cholesterol ester transfer protein inhibitor.
Nucleoside (deoxycytidine) analog; DNMT inhibit...
Natriuretic, vasodilatory peptide fragment; B1/...
Impurity of diclofenac
Neurotoxin, mutagen.
Nucleoside (guanosine) analog; DNA chain termin...
PKC and S6 kinase substrate.
HDAC inhibitor.
pan-Raf inhibitor.
MET and GSK-3α/β inhibitor.
Triazolothienodiazepine; BRD inhibitor.
Protease inhibitor.
CB1 inverse agonist.
Selective positive allosteric modulator of AMPA...
β2-adrenergic agonist.